Free Trial

Aurora Cannabis (ACB) Competitors

Aurora Cannabis logo
$4.47 +0.17 (+3.95%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$4.46 0.00 (-0.11%)
As of 07:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ACB vs. ARDX, ZYME, LENZ, OCS, ORIC, PRAX, COGT, CMRX, CDMO, and AVXL

Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Ardelyx (ARDX), Zymeworks (ZYME), LENZ Therapeutics (LENZ), Oculis (OCS), Oric Pharmaceuticals (ORIC), Praxis Precision Medicines (PRAX), Cogent Biosciences (COGT), Chimerix (CMRX), Avid Bioservices (CDMO), and Anavex Life Sciences (AVXL). These companies are all part of the "pharmaceutical products" industry.

Aurora Cannabis vs. Its Competitors

Aurora Cannabis (NASDAQ:ACB) and Ardelyx (NASDAQ:ARDX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations, media sentiment and institutional ownership.

47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 58.9% of Ardelyx shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 4.8% of Ardelyx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Ardelyx had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 6 mentions for Ardelyx and 5 mentions for Aurora Cannabis. Ardelyx's average media sentiment score of 0.61 beat Aurora Cannabis' score of 0.15 indicating that Ardelyx is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ardelyx
0 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Aurora Cannabis has higher earnings, but lower revenue than Ardelyx. Ardelyx is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora Cannabis$246.72M1.02$1.63M$0.1140.64
Ardelyx$333.61M3.01-$39.14M-$0.22-19.05

Ardelyx has a consensus target price of $10.89, suggesting a potential upside of 159.88%. Given Ardelyx's higher probable upside, analysts clearly believe Ardelyx is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.67
Ardelyx
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
3.00

Aurora Cannabis has a net margin of 1.32% compared to Ardelyx's net margin of -14.86%. Aurora Cannabis' return on equity of 0.13% beat Ardelyx's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis1.32% 0.13% 0.10%
Ardelyx -14.86%-34.45%-13.81%

Aurora Cannabis has a beta of 1.75, suggesting that its stock price is 75% more volatile than the S&P 500. Comparatively, Ardelyx has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500.

Summary

Aurora Cannabis beats Ardelyx on 9 of the 17 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACB vs. The Competition

MetricAurora CannabisMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$241.72M$10.49B$5.54B$8.87B
Dividend YieldN/A2.09%5.39%4.10%
P/E Ratio40.6416.6626.2319.90
Price / Sales1.0229.93413.23113.66
Price / Cash7.0322.7836.1356.90
Price / Book0.573.648.045.38
Net Income$1.63M$233.36M$3.15B$248.50M
7 Day Performance4.93%1.00%1.44%2.04%
1 Month Performance-16.76%3.01%3.62%4.84%
1 Year Performance-8.78%-11.64%34.68%20.23%

Aurora Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACB
Aurora Cannabis
0.2936 of 5 stars
$4.47
+4.0%
N/A-1.1%$241.72M$246.72M40.641,130
ARDX
Ardelyx
4.3664 of 5 stars
$3.63
+2.0%
$10.89
+200.0%
-20.6%$868.51M$333.61M-16.5090
ZYME
Zymeworks
1.9669 of 5 stars
$12.47
-0.1%
$21.00
+68.4%
+53.5%$867.63M$93.38M-8.31460
LENZ
LENZ Therapeutics
1.3529 of 5 stars
$30.48
+1.8%
$46.60
+52.9%
+76.5%$858.01MN/A-17.22110
OCS
Oculis
2.1866 of 5 stars
$19.65
+1.9%
$35.33
+79.8%
+63.8%$857.92M$780K-7.442
ORIC
Oric Pharmaceuticals
4.235 of 5 stars
$10.00
+7.4%
$19.17
+91.7%
+41.6%$852.20MN/A-5.3580
PRAX
Praxis Precision Medicines
3.2703 of 5 stars
$41.63
-1.7%
$109.90
+164.0%
+18.0%$848.00M$8.55M-3.88110News Coverage
Positive News
COGT
Cogent Biosciences
2.7428 of 5 stars
$7.26
+0.4%
$14.57
+100.7%
-10.1%$826.62MN/A-3.9580Positive News
Analyst Forecast
Analyst Revision
CMRX
Chimerix
0.6762 of 5 stars
$8.54
flat
$8.53
-0.1%
N/A$801.09M$212K-9.0990
CDMO
Avid Bioservices
0.9274 of 5 stars
$12.50
+0.1%
$12.25
-2.0%
+86.5%$799.18M$139.91M-5.23320News Coverage
High Trading Volume
AVXL
Anavex Life Sciences
3.9142 of 5 stars
$9.30
+2.3%
$44.00
+373.1%
+155.9%$793.94MN/A-16.9140News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:ACB) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners